within Pharmacolibrary.Drugs.ATC.G;

model G04BE09
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.15,
    Cl             = 0.0009333333333333333,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.117,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.024166666666666666,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.122,
    k12             = 122,
    k21             = 122
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04BE09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor, used to treat erectile dysfunction in men. It works by increasing blood flow to the penis during sexual stimulation. Vardenafil is approved and currently available as a prescription medicine in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult males following a single oral dose.</p><h4>References</h4><ol><li><p>Wang, J, et al., &amp; White, S (2023). Pharmacokinetics comparison of vardenafil as administered by an intranasal spray formulation vs a 10-mg oral tablet. <i>The journal of sexual medicine</i> 20(7) 1004–1009. DOI:<a href=\"https://doi.org/10.1093/jsxmed/qdad056\">10.1093/jsxmed/qdad056</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37147929/\">https://pubmed.ncbi.nlm.nih.gov/37147929</a></p></li><li><p>Sanford, M (2012). Vardenafil orodispersible tablet. <i>Drugs</i> 72(1) 87–98. DOI:<a href=\"https://doi.org/10.2165/11208270-000000000-00000\">10.2165/11208270-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22191797/\">https://pubmed.ncbi.nlm.nih.gov/22191797</a></p></li><li><p>Abou-Taleb, HA, et al., &amp; Abdelkader, H (2022). Vardenafil Oral Dispersible Films (ODFs) with Advanced Dissolution, Palatability, and Bioavailability. <i>Pharmaceutics</i> 14(3) –. DOI:<a href=\"https://doi.org/10.3390/pharmaceutics14030517\">10.3390/pharmaceutics14030517</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35335893/\">https://pubmed.ncbi.nlm.nih.gov/35335893</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04BE09;
